Cardiometabolism in Health and Disease (J6)
January 26-29, 2026
| Keystone Resort, Keystone, CO, United States
Daniel P Kelly, Rong Tian and William C. Sessa
Scholarship Deadline: Sep. 25, 2025 | Abstract Deadline: Jan. 6, 2026 | Early Registration Deadline: Nov. 25, 2025
| 4:00–8:00 PM |
Registration |
|
| 6:00–8:00 PM |
Welcome Mixer |
|
Tuesday, January 27, 2026
| 8:00–9:00 AM |
Welcome and Keynote Address (Joint) |
|
| |
Richard D DiMarchi, Indiana University
The Chemical Evolution of Peptides To Transform Human Health |
|
| 9:00–11:15 AM |
Beyond Weight Loss: New Directions for Obesity Therapeutics (Joint) |
|
| |
Rachel J. Roth Flach, Valo Health
Targeting Metabolism for HFpEF |
|
| |
Susan Quaggin, Northwestern University
A United Vision for Kidney and Cardiovascular Disease Treatment |
|
| |
James Trevaskis, Eli Lilly
Incretins for MASH Treatment |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
|
| 11:15–12:15 PM |
Meet the Editors (Joint) |
|
| |
* Rong Tian, University of Washington
|
|
| 11:15–1:00 PM |
Poster Setup |
|
| 12:15–2:30 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 2:30–4:30 PM |
Symposia Spotlight 1: Emerging Therapies, Lifestyle Interventions and AI Approaches |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Metabolic Origins of Heart Health and Disease |
|
| |
Daniel P Kelly, University of Pennsylvania
Modulating Cardiac Maturation in the Failing Heart |
|
| |
Catherine Makarewich, Cincinnati Children's Hospital Medical Center
Microproteins as Targets in the Diseased Heart |
|
| |
David A. Kass, Johns Hopkins Hospital
Integrated OMIC and Physiologic Interrogation of HFpEF |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 7:30–10:00 PM |
Poster Session 1 |
|
Wednesday, January 28, 2026
| 8:00–11:00 AM |
Metabolic Contributions to Vascular Health and Disease |
|
| |
William C. Sessa, Yale School of Medicine
Probing Trans-Vascular Lipid Trafficking |
|
| |
Katrien De Bock, Swiss Federal Institute of Technology
Metabolic Determinants of Angiogenesis in Disease States |
|
| |
Yajaira Suarez, Yale School of Medicine
Regulators of Macrophage or Endothelial Cell Functions in Atherosclerosis |
|
| |
Zoltan Arany, University of Pennsylvania
Metabolic Determinants of Vascular Function |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–1:00 PM |
Poster Setup |
|
| 11:00–3:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 1:30–2:45 PM |
Career Roundtable (Joint) |
|
| 3:00–4:30 PM |
Panel Discussion: SGLT2 and GLP-1: Potential Mechanisms of Cardioprotective Actions |
|
| |
* Daniel P Kelly, University of Pennsylvania
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Mitochondria and Cardiometabolic Disease |
|
| |
Rong Tian, University of Washington
Mitochondria in HFpEF |
|
| |
E. Dale Abel, David Geffen School of Medicine and UCLA Health
Mitochondrial Dynamics and Cardiometabolic Disease |
|
| |
Yibin Wang, Duke-NUS, Singapore
Branched-Chain Amino Acid Metabolism in the Failing Heart |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 7:30–10:00 PM |
Poster Session 2 |
|
Thursday, January 29, 2026
| 8:00–11:00 AM |
Emerging Therapies for Obesity and Cardiometabolic Diseases (Joint) |
|
| |
Matthias H. Tschöp, Helmholtz Munich
Dual and Triple Co-Agonists: From Discovery to Best-in-Class |
|
| |
Kirsten Raun, Novo Nordisk A/S
Amylin: The All-Inclusive Obesity Therapeutic |
|
| |
Thomas Alexander Lutz, University of Zürich
Amylin Physiology and its Therapeutic Potential to Treat Metabolic Diseases |
|
| |
Murielle M Véniant-Ellison, Amgen Inc.
Unlocking the Power of GIPR and GLP-1R Targeting for Effective Weight Loss and Metabolic Improvement |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–2:30 PM |
On Own for Lunch |
|
| 1:00–2:00 PM |
Panel: Perspectives: Personalized Medicine & Patient-Centered Strategies (Joint) |
|
| 2:30–4:30 PM |
Symposia Spotlight 2: Leverage AI for Biomedical Research |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–6:45 PM |
Environmental and Social Modulators of CV Health and Disease |
|
| |
Martin E. Young, University of Alabama at Birmingham
Circadian Control of the Heart in Health and Disease |
|
| |
Danica Chen, University of California, Berkeley
Aging and Cardiovascular Health |
|
| |
Tiffany M Powell-Wiley, NHLBI, National Institutes of Health
Social Determinants of Obesity and Cardiovascular Risk |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 6:45–7:00 PM |
Meeting Wrap-Up: Outcomes and Future Directions (Organizers) |
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 PM |
Entertainment |
|
